Total Payments
$56,351
2024 Payments
$15,398
Companies
30
Transactions
787
Medicare Patients
496
Medicare Billing
$54,781
Payment Breakdown by Category
Other$24,270 (43.1%)
Consulting$13,415 (23.8%)
Food & Beverage$13,130 (23.3%)
Travel$5,123 (9.1%)
Education$413.22 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,770 | 8 | 35.1% |
| Consulting Fee | $13,415 | 6 | 23.8% |
| Food and Beverage | $13,130 | 742 | 23.3% |
| Travel and Lodging | $5,123 | 19 | 9.1% |
| Honoraria | $4,500 | 3 | 8.0% |
| Education | $413.22 | 9 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $25,250 | 207 | $0 (2024) |
| Merck Sharp & Dohme LLC | $13,895 | 93 | $0 (2024) |
| Theratechnologies Inc. | $7,107 | 64 | $0 (2024) |
| Gilead Sciences, Inc. | $4,548 | 172 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,617 | 5 | $0 (2021) |
| Janssen Biotech, Inc. | $1,266 | 96 | $0 (2023) |
| ABBVIE INC. | $758.38 | 38 | $0 (2024) |
| EMD Serono, Inc. | $416.05 | 27 | $0 (2023) |
| Janssen Products, LP | $275.03 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $259.53 | 19 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,398 | 86 | Merck Sharp & Dohme LLC ($12,721) |
| 2023 | $4,169 | 62 | Theratechnologies Inc. ($3,052) |
| 2022 | $20,217 | 55 | ViiV Healthcare Company ($16,752) |
| 2021 | $8,886 | 116 | ViiV Healthcare Company ($6,149) |
| 2020 | $1,421 | 76 | Gilead Sciences, Inc. ($386.47) |
| 2019 | $2,505 | 154 | Gilead Sciences, Inc. ($772.17) |
| 2018 | $1,980 | 126 | Gilead Sciences, Inc. ($813.35) |
| 2017 | $1,776 | 112 | ViiV Healthcare Company ($250.01) |
All Payment Transactions
787 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: HIV | ||||||
| 12/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: HIV | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $112.20 | General |
| Category: HIV | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $687.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $395.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/27/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: HIV | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: HIV | ||||||
| 11/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/05/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: HIV | ||||||
| 11/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: HIV | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $1,137.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $353.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $178.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $119.17 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/23/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: HIV | ||||||
| 10/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: HIV | ||||||
| 10/09/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $39.53 | General |
| Category: HIV | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.63 | General |
| 10/09/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: HIV | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 150 | 180 | $124,654 | $20,986 |
| 2022 | 6 | 159 | 166 | $103,889 | $18,897 |
| 2021 | 4 | 83 | 147 | $16,704 | $8,480 |
| 2020 | 5 | 104 | 149 | $14,685 | $6,418 |
Total Patients
496
Total Services
642
Medicare Billing
$54,781
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 122 | 125 | $109,625 | $16,917 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 43 | $7,529 | $2,831 | 37.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $7,500 | $1,237 | 16.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $36,834 | $6,636 | 18.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 44 | 44 | $33,264 | $6,101 | 18.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 27 | 27 | $13,959 | $2,086 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 29 | $5,396 | $1,548 | 28.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $7,236 | $1,271 | 17.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $7,200 | $1,255 | 17.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 69 | $10,350 | $4,864 | 47.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 45 | $4,500 | $2,467 | 54.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 20 | $1,300 | $669.02 | 51.5% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 13 | 13 | $554.00 | $481.04 | 86.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 46 | $6,900 | $2,484 | 36.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 41 | $4,100 | $1,989 | 48.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 27 | $1,399 | $822.66 | 58.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 18 | 21 | $1,376 | $684.95 | 49.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 14 | $910.00 | $436.32 | 47.9% |
About Dr. Mohammed Reza, MD
Dr. Mohammed Reza, MD is a Infectious Disease healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1174753933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Reza, MD has received a total of $56,351 in payments from pharmaceutical and medical device companies, with $15,398 received in 2024. These payments were reported across 787 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,770).
As a Medicare-enrolled provider, Reza has provided services to 496 Medicare beneficiaries, totaling 642 services with total Medicare billing of $54,781. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Jacksonville, FL
- Active Since 07/15/2009
- Last Updated 03/07/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1174753933
Products in Payments
- DOVATO (Drug) $20,860
- PIFELTRO (Drug) $13,124
- EGRIFTA SV (Drug) $4,565
- SYMTUZA (Drug) $2,100
- TROGARZO (Drug) $1,469
- EGRIFTA (Drug) $1,073
- ISENTRESS (Drug) $725.15
- PREZCOBIX (Drug) $629.96
- MAVYRET (Drug) $486.31
- CABENUVA (Biological) $485.77
- Symtuza (Drug) $400.30
- APRETUDE (Biological) $315.70
- TRIUMEQ (Drug) $285.16
- SEROSTIM (Biological) $268.39
- JULUCA (Drug) $255.33
- Mavyret (Drug) $229.17
- BEVESPI AEROSPHERE (Drug) $161.67
- RUKOBIA (Drug) $159.96
- Descovy (Drug) $118.74
- JARDIANCE (Drug) $110.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Jacksonville
Dr. Pablo Pella, Md, MD
Infectious Disease — Payments: $139,265
Infectious Disease $139,265
Daniela Chiriboga-Salazar, M.d, M.D
Infectious Disease — Payments: $77,648
Infectious Disease $77,648
Robert Catalla, Md, MD
Infectious Disease — Payments: $48,830
Infectious Disease $48,830
Shalika Katugaha, Md, MD
Infectious Disease — Payments: $40,883
Infectious Disease $40,883
Ivan Guerrero, Md, MD
Infectious Disease — Payments: $26,872
Infectious Disease $26,872
Julio Mendez, Md, MD
Infectious Disease — Payments: $21,357
Infectious Disease $21,357